Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Insulin resistance7794 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A25805 | 21440669 | Clin Gastroenterol Hepatol | Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008. | 2011 | Details |
| A25808 | 21439567 | Atherosclerosis | Diet, commensals and the intestine as sources of pathogen-associated molecular patterns in atherosclerosis, type 2 diabetes and non-alcoholic fatty liver disease. | 2011 | Details |
| A25809 | 21438811 | Expert Rev Cardiovasc Ther | Hepatic steatosis and Type 2 diabetes: current and future treatment considerations. | 2011 | Details |
| A25811 | 21436212 | J Renin Angiotensin Aldosterone Syst | Effect of spironolactone and vitamin E on serum metabolic parameters and insulin resistance in patients with nonalcoholic fatty liver disease. | 2011 | Details |
| A25812 | 21436037 | Proc Natl Acad Sci U S A | Hepatic insulin resistance in mice with hepatic overexpression of diacylglycerol acyltransferase 2. | 2011 | Details |
| A25814 | 21431854 | Curr Diab Rep | Why does NAFLD predict type 2 diabetes? | 2011 | Details |
| A25818 | 21429628 | Gastroenterol Hepatol | [Non-alcoholic fatty liver disease. How and who to screen]. | 2011 | Details |
| A25821 | 21427524 | J Endocrinol Invest | Risk of cardiovascular disease and chronic kidney disease in diabetic patients with non-alcoholic fatty liver disease: just a coincidence? | 2011 | Details |
| A25822 | 21426695 | Zhonghua Er Ke Za Zhi | [Metformin prevents non-alcoholic fatty liver disease in rats: role of phospholipase A2/lysophosphatidylcholine lipoapoptosis pathway in hepatocytes]. | 2011 | Details |
| A25829 | 21418702 | Ned Tijdschr Geneeskd | [No-invasive determination of liver fat with 1H-MR spectroscopy]. | 2011 | Details |
| A25834 | 21414047 | J Intern Med | Nonalcoholic fatty liver disease: an independent risk factor for colorectal neoplasia. | 2011 | Details |
| A25835 | 21412813 | Hepatology | Pancreatic-derived factor promotes lipogenesis in the mouse liver: role of the Forkhead box 1 signaling pathway. | 2011 | Details |
| A25837 | 21411114 | Metabolism | Treatment with insulin sensitizer metformin improves arterial properties, metabolic parameters, and liver function in patients with nonalcoholic fatty liver disease: a randomized, placebo-controlled trial. | 2011 | Details |
| A25838 | 21410952 | J Inflamm (Lond) | Inflammatory Signals shift from adipose to liver during high fat feeding and influence the development of steatohepatitis in mice. | 2011 | Details |
| A25846 | 21401320 | Arch Physiol Biochem | IRS2 and PTP1B: Two opposite modulators of hepatic insulin signalling. | 2011 | Details |
| A25850 | 21395631 | Aliment Pharmacol Ther | Enteric-coated cysteamine for the treatment of paediatric non-alcoholic fatty liver disease. | 2011 | Details |
| A25853 | 21390143 | World J Gastroenterol | Non-alcoholic fatty liver disease: An early mediator predicting metabolic syndrome in obese children? | 2011 | Details |
| A25858 | 21383997 | Acta Biochim Pol | Retinol binding protein-4 as a serum biomarker of intrahepatic lipid content in obese children--preliminary report. | 2011 | Details |
| A25861 | 21382165 | Liver Int | A novel and comprehensive mouse model of human non-alcoholic steatohepatitis with the full range of dysmetabolic and histological abnormalities induced by gold thioglucose and a high-fat diet. | 2011 | Details |
| A25865 | 21378763 | Am J Gastroenterol | Editorial: Exercise for NAFLD: does intensity matter? | 2011 | Details |
| A25866 | 21378565 | Curr Opin Lipidol | Lipidomics is providing new insight into the metabolic syndrome and its sequelae. | 2011 | Details |
| A25870 | 21374659 | Hepatology | Gender-specific differences in adipose distribution and adipocytokines influence adolescent nonalcoholic fatty liver disease. | 2011 | Details |
| A25871 | 21373917 | Internist (Berl) | [Nonalcoholic steatohepatitis. Predictor and consequence of diabetes]. | 2011 | Details |
| A25876 | 21364120 | Am J Physiol Endocrinol Metab | Rhein ameliorates fatty liver disease through negative energy balance, hepatic lipogenic regulation, and immunomodulation in diet-induced obese mice. | 2011 | Details |
| A25881 | 21356259 | J Hepatol | Insulin resistance and liver microcirculation in a rat model of early NAFLD. | 2011 | Details |
| A25882 | 21356258 | J Hepatol | Intravenous administration of multipotent stromal cells prevents the onset of non-alcoholic steatohepatitis in obese mice with metabolic syndrome. | 2011 | Details |
| A25887 | 21352073 | Expert Opin Emerg Drugs | Treatment of non-alcoholic fatty liver disease with focus on emerging drugs. | 2011 | Details |
| A25891 | 21350183 | Am J Physiol Gastrointest Liver Physiol | Obesity, diabetes mellitus, and liver fibrosis. | 2011 | Details |
| A25894 | 21348181 | G Ital Cardiol (Rome) | [Non-alcoholic fatty liver disease: a new challenge for cardiologists]. | 2010 | Details |
| A25902 | 21340530 | J Gastroenterol | Hybrid training of voluntary and electrical muscle contractions reduces steatosis, insulin resistance, and IL-6 levels in patients with NAFLD: a pilot study. | 2011 | Details |
| A25908 | 21336428 | Nutr Hosp | Effect of two different hypocaloric diets in transaminases and insulin resistance in nonalcoholic fatty liver disease and obese patients. | 2011 | Details |
| A25909 | 21336425 | Nutr Hosp | Is liver transaminases assessment an appropriate tool for the screening of non-alcoholic fatty liver disease in at risk obese children and adolescents? | 2011 | Details |
| A25910 | 21335212 | Transplant Proc | Metabolic syndrome in transplant patients: an academic or a health burden? | 2011 | Details |
| A25912 | 21333494 | Nutrition | Soy protein retards the progression of non-alcoholic steatohepatitis via improvement of insulin resistance and steatosis. | 2011 | Details |
| A25921 | 21325464 | J Clin Endocrinol Metab | Up-regulation of PPAR-gamma mRNA expression in the liver of obese patients: an additional reinforcing lipogenic mechanism to SREBP-1c induction. | 2011 | Details |
| A25922 | 21325336 | Acta Biochim Biophys Sin (Shanghai) | PGC-1 coactivators in the control of energy metabolism. | 2011 | Details |
| A25923 | 21324757 | Dig Liver Dis | High liver RBP4 protein content is associated with histological features in patients with genotype 1 chronic hepatitis C and with nonalcoholic steatohepatitis. | 2011 | Details |
| A25935 | 21301010 | Ann Hepatol | Relation of osteocalcin with insulin resistance and histopathological changes of non alcoholic fatty liver disease. | 2011 | Details |
| A25938 | 21299150 | Acta Gastroenterol Belg | Dietary lipids and NAFLD: suggestions for improved nutrition. | 2011 | Details |
| A25939 | 21292470 | J Nutr Biochem | Probiotics as an emerging therapeutic strategy to treat NAFLD: focus on molecular and biochemical mechanisms. | 2011 | Details |
| A25945 | 21281435 | Liver Int | Association of PNPLA3 with non-alcoholic fatty liver disease in a minority cohort: the Insulin Resistance Atherosclerosis Family Study. | 2011 | Details |
| A25947 | 21280192 | Liver Transpl | Endoplasmic reticulum stress is a mediator of posttransplant injury in severely steatotic liver allografts. | 2011 | Details |
| A25950 | 21274868 | Hepatology | Dissociation between APOC3 variants, hepatic triglyceride content and insulin resistance. | 2010 | Details |
| A25954 | 21270117 | Gut | Hepatic fatty acid translocase CD36 upregulation is associated with insulin resistance, hyperinsulinaemia and increased steatosis in non-alcoholic steatohepatitis and chronic hepatitis C. | 2011 | Details |
| A25957 | 21267748 | J Gastroenterol | Clinical characteristics of de novo nonalcoholic fatty liver disease following pancreaticoduodenectomy. | 2011 | Details |
| A25965 | 21256090 | Epilepsy Behav | Nonalcoholic fatty liver disease in adolescents receiving valproic acid. | 2011 | Details |
| A25971 | 21251450 | Acta Dermatovenerol Croat | Metabolic comorbidities and psoriasis. | 2010 | Details |
| A25972 | 21251033 | Aliment Pharmacol Ther | Systematic review: association of polycystic ovary syndrome with metabolic syndrome and non-alcoholic fatty liver disease. | 2011 | Details |
| A25974 | 21249309 | Biol Res | Cytoprotective and suicidal signaling in oxidative stress. | 2010 | Details |
| A25976 | 21246004 | World J Gastroenterol | Potential efficacy of ginger as a natural supplement for nonalcoholic fatty liver disease. | 2011 | Details |
| A25978 | 21245030 | J Lipid Res | Genetic determinants of hepatic steatosis in man. | 2011 | Details |
| A25989 | 21233083 | Arch Dis Child | Docosahexaenoic acid supplementation decreases liver fat content in children with non-alcoholic fatty liver disease: double-blind randomised controlled clinical trial. | 2011 | Details |
| A25993 | 21226276 | Nihon Rinsho | [Chronic liver disease and arteriosclerosis]. | 2011 | Details |
| A25994 | 21199528 | J Gastroenterol Hepatol | Nonalcoholic fatty liver in Asia: Firmly entrenched and rapidly gaining ground. | 2011 | Details |
| A26004 | 21218508 | Diabetes Metab Res Rev | Metformin and atorvastatin combination further protect the liver in type 2 diabetes with hyperlipidaemia. | 2011 | Details |
| A26005 | 21216282 | Biochim Biophys Acta | Lipotoxicity and steatohepatitis in an overfed mouse model for non-alcoholic fatty liver disease. | 2011 | Details |
| A26006 | 21216209 | Endocrinol Nutr | [Fatty liver and its clinical management in obese adolescents]. | 2011 | Details |
| A26012 | 21205607 | Orv Hetil | [Role of the brain in the regulation of metabolism and energy expenditure: the central role of insulin, and insulin resistance of the brain]. | 2011 | Details |
| A26017 | 21196652 | Saudi J Gastroenterol | Predictors of non-alcoholic fatty liver disease in obese and overweight Egyptian children: single center study. | 2011 | Details |
| A26025 | 22566839 | Front Immunol | New insights into the role of macrophages in adipose tissue inflammation and Fatty liver disease: modulation by endogenous omega-3 Fatty Acid-derived lipid mediators. | 2011 | Details |
| A26026 | 21191681 | Indian J Gastroenterol | Nonalcoholic fatty liver disease in India - a lot done, yet more required! | 2010 | Details |
| A26029 | 21188334 | J Gastrointestin Liver Dis | An overview of nonalcoholic steatohepatitis: past, present and future directions. | 2010 | Details |
| A26030 | 21187187 | Am J Med | Hyperinsulinemia and the development of nonalcoholic Fatty liver disease in nondiabetic adults. | 2011 | Details |
| A26038 | 21180596 | Therap Adv Gastroenterol | Treatment options for nonalcoholic fatty liver disease. | 2010 | Details |
| A26039 | 21179000 | Int J Obes (Lond) | Reproducibility of glucose, fatty acid and VLDL kinetics and multi-organ insulin sensitivity in obese subjects with non-alcoholic fatty liver disease. | 2010 | Details |
| A26044 | 21168460 | J Hepatol | Early interplay of intra-hepatic iron and insulin resistance in children with non-alcoholic fatty liver disease. | 2010 | Details |
| A26051 | 21166266 | Bull Mem Acad R Med Belg | Non-alcoholic fatty liver disease. | 2010 | Details |
| A26053 | 21161009 | World J Hepatol | Pediatric nonalcoholic fatty liver disease: A clinical and laboratory challenge. | 2010 | Details |
| A26055 | 21160946 | World J Hepatol | Current status and agenda in the diagnosis of nonalcoholic steatohepatitis in Japan. | 2010 | Details |
| A26056 | 21157426 | Int J Obes (Lond) | Daidzein supplementation prevents non-alcoholic fatty liver disease through alternation of hepatic gene expression profiles and adipocyte metabolism. | 2010 | Details |
| A26057 | 21155882 | J Gastroenterol Hepatol | Postprandial hyperinsulinemia is universal in non-diabetic patients with nonalcoholic fatty liver disease. | 2011 | Details |
| A26063 | 21147154 | Prev Med | Nonalcoholic fatty liver disease is associated with insulin resistance in a young Hispanic population. | 2010 | Details |
| A26066 | 21145850 | J Hepatol | Risk of chronic kidney disease in patients with non-alcoholic fatty liver disease: is there a link? | 2010 | Details |
| A26068 | 21145841 | J Hepatol | Risk of nonalcoholic steatohepatitis and fibrosis in patients with nonalcoholic fatty liver disease and low visceral adiposity. | 2010 | Details |
| A26072 | 21145828 | J Hepatol | A randomized controlled trial of high-dose ursodesoxycholic acid for nonalcoholic steatohepatitis. | 2010 | Details |
| A26073 | 21145823 | J Hepatol | Galectin-3 ablation protects mice from diet-induced NASH: a major scavenging role for galectin-3 in liver. | 2010 | Details |
| A26078 | 21139538 | Minerva Gastroenterol Dietol | [Non-alcoholic hepatic steatosis: the role of policosanols in associated hyperlipidemia]. | 2010 | Details |
| A26082 | 21134109 | Liver Int | Increased coagulation factor VIII, IX, XI and XII activities in non-alcoholic fatty liver disease. | 2010 | Details |
| A26083 | 21130626 | Arch Pediatr | [Nonalcoholic fatty liver disease in a severely obese adolescent. An arguable liver biopsy]. | 2010 | Details |
| A26087 | 21126940 | Environ Health Perspect | Polychlorinated biphenyls, lead, and mercury are associated with liver disease in American adults: NHANES 2003-2004. | 2010 | Details |
| A26088 | 21126792 | J Hepatol | Smoking and severity of hepatic fibrosis in nonalcoholic fatty liver disease. | 2010 | Details |
| A26091 | 21119613 | Nat Rev Gastroenterol Hepatol | Animal models of nonalcoholic fatty liver disease. | 2010 | Details |
| A26105 | 21091931 | J Dig Dis | Epidemiology of the metabolic syndrome in the USA. | 2011 | Details |
| A26106 | 21091060 | Metab Syndr Relat Disord | Insulin resistance is independently associated with liver aminotransferases in diabetic patients without ultrasound signs of nonalcoholic fatty liver disease. | 2010 | Details |
| A26108 | 21084751 | J Clin Invest | Salt-inducible kinase 2 links transcriptional coactivator p300 phosphorylation to the prevention of ChREBP-dependent hepatic steatosis in mice. | 2010 | Details |
| A26114 | 21073123 | J Pediatr Endocrinol Metab | Mean platelet volume in obese adolescents with nonalcoholic fatty liver disease. | 2010 | Details |
| A26118 | 21071306 | Orv Hetil | [Fatty liver and global cardiometabolic risk]. | 2010 | Details |
| A26119 | 21071305 | Orv Hetil | [Non-alcoholic steatosis/steatohepatitis -- 2010]. | 2010 | Details |
| A26121 | 21067942 | Trends Endocrinol Metab | Fructose induced lipogenesis: from sugar to fat to insulin resistance. | 2010 | Details |
| A26123 | 21057163 | Ann Hepatol | G308A polymorphism of TNF-alpha gene is associated with insulin resistance and histological changes in non alcoholic fatty liver disease patients. | 2011 | Details |
| A26126 | 21055684 | Clin Liver Dis | Nonalcoholic fatty liver disease. | 2010 | Details |
| A26127 | 21054523 | J Gastroenterol Hepatol | Postprandial insulin secretion pattern is associated with histological severity in non-alcoholic fatty liver disease patients without prior known diabetes mellitus. | 2011 | Details |
| A26131 | 21045794 | Nat Rev Gastroenterol Hepatol | The role of the gut microbiota in nonalcoholic fatty liver disease. | 2010 | Details |
| A26136 | 21042270 | Minerva Pediatr | [Pediatric non-alcoholic fatty liver disease: recent advances and challenges]. | 2010 | Details |
| A26138 | 21040936 | Metabolism | The association between the metabolic syndrome and alanine amino transferase is mediated by insulin resistance via related metabolic intermediates (the Cohort on Diabetes and Atherosclerosis Maastricht [CODAM] study). | 2010 | Details |
| A26140 | 21040407 | Liver Int | Anabolic-androgenic steroids: a possible new risk factor of toxicant-associated fatty liver disease. | 2010 | Details |
| A26153 | 21033079 | Eksp Klin Gastroenterol | [Non-alcoholic fatty liver disease as an atherosclerosis risk factor]. | 2010 | Details |
| A26154 | 23051943 | Indian J Med Sci | Cryptogenic cirrhosis: metabolic liver disease due to insulin resistance. | 2010 | Details |
| A26155 | 21030787 | Exp Anim | Inducible nitric oxide distribution in the fatty liver of a mouse with high fat diet-induced obesity. | 2010 | Details |
| A26156 | 21029639 | Zhonghua Yi Xue Za Zhi | [Effect of obesity on nonalcoholic fatty liver disease in Chinese women with polycystic ovary syndrome]. | 2010 | Details |